Late Ovarian Impairment Occurs Frequently After CHOP-Like Chemo for Lymphoma

Share this content:
Although most female patients regain fertility after CHOP-like chemotherapy for aggressive lymphoma, late ovarian impairment occurs frequently.
Although most female patients regain fertility after CHOP-like chemotherapy for aggressive lymphoma, late ovarian impairment occurs frequently.

Although most female patients regain fertility after CHOP-like chemotherapy for aggressive lymphoma, late ovarian impairment occurs frequently in these patients, a new study published online in the journal Annals of Oncology has shown.

Results of the study showed that during a median follow-up of 14 years, late menstrual bleeding occurred significantly earlier in patients compared with the general population (47 years vs 51 years; P < 0.0001) and a higher percentage of patients experienced moderate to severe menopausal symptoms than the general population.

Laboratory analyses showed that anti-Muller-hormone (AMH) was decreased in patients when compared with correspondent age groups in the general population. AMH is a marker of ovarian reserve.

RELATED: Poor Outcomes in T-cell Lymphoma CNS Relapse Driven Mostly By Systemic Disease

For the study, researchers surveyed 46 long-term survivors of aggressive non-Hodgkin lymphoma who received CHOP or CHOP plus etoposide treatment within the Mabthera International Trial or the NHL B1 trial of the German NHL Study Group. Participants also underwent blood sampling for hormone replacement.

Chemotherapy-associated ovarian damage has been associated with alkylating chemotherapy for breast cancer or Hodgkin's lymphoma, and can result in infertility and premature menopause.

Reference

  1. Meissner J, Tichy D, Katzke V, et al. Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma. Ann Oncol. 2015. [Epub ahead of print]. doi: 10.1093/annonc/mdv227.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters